Trial Profile
A Multicenter Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postsurgical Analgesia in Pediatric Subjects Aged 6 to Less Than 17 Years
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics; Registrational
- Acronyms PLAY
- Sponsors Pacira BioSciences
- 05 Oct 2020 Results presented at the ANESTHESIOLOGY 2020 Annual Meeting of the American Society of Anesthesiologists
- 17 Dec 2019 Results presented in a Pacira BioSciences Media Release.
- 17 Dec 2019 According to a Pacira BioSciences media release, the full study results will be submitted for publication in the peer-reviewed medical literature later this year.